Response of EMT6 Multicellular Tumour Spheroids to Hyperthermia and Cytotoxic Drugs
Overview
Authors
Affiliations
The response of multicellular tumour spheroids of the EMT6 cell line to combinations of hyperthermia and Bleomycin (BLM) or Adriamycin (ADM) has been investigated. Using this model system, we have demonstrated enhanced BLM cytotoxicity at 43 degrees C and also heat-induced drug tolerance to BLM at 43 degrees C. ADM cytotoxicity was not significantly increased after 43 degrees C x 1 h but after 6 h at 42 degrees C greatly enhanced cell-killing was evident. These results are discussed in relation to our previous data for EMT6 cells growing either as monolayer cultures in vitro or as solid tumours in mice.
Kleeberger L, Rottinger E Cancer Chemother Pharmacol. 1993; 33(2):144-8.
PMID: 8261573 DOI: 10.1007/BF00685332.
Ben-Hur E, Shaw J, Bleehen N Br J Cancer. 1983; 47(1):51-5.
PMID: 6821633 PMC: 2011250. DOI: 10.1038/bjc.1983.6.
Multicellular spheroids. A review on cellular aggregates in cancer research.
Mueller-Klieser W J Cancer Res Clin Oncol. 1987; 113(2):101-22.
PMID: 3549738 DOI: 10.1007/BF00391431.
Hyperthermia in cancer therapy.
Otte J Eur J Pediatr. 1988; 147(6):560-9.
PMID: 3053187 DOI: 10.1007/BF00442463.
A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids.
West C, Stratford I Cancer Chemother Pharmacol. 1987; 20(2):109-14.
PMID: 2822273 DOI: 10.1007/BF00253963.